Can a medication help prevent kidney disease from returning after transplant?

Imagine finally getting a new kidney after living with a serious disease called FSGS, only to worry that the disease might attack your new organ. That's the reality for many transplant patients. This study focused on that exact fear. It followed 15 patients with FSGS who received a kidney transplant. The main goal was to see if giving them a medication called Acthar could change the rate at which FSGS came back. The disease's return is typically tracked in two ways: by checking a biopsy of the new kidney and by measuring protein in the urine, a sign of kidney damage. Based on existing data, the researchers expected about 23% of patients (which would be at least 4 people in this group) to see their FSGS return after the transplant. The study aimed to see if Acthar made a difference in that number. All patients also received standard anti-rejection medication. The study has finished, and the results are now available for review.